NEWS: Sanders and Colleagues Move to Block Arms Sales to Israel
WASHINGTON, Sept. 25 — Sen. Bernie Sanders (I-Vt.) today introduced Joint Resolutions of Disapproval to block the sale of more than $20 billion in offensive U.S. weaponry to Israel. Sanders spoke last week on the Senate floor about why the sales must not move forward and today issued the following statement: Today, with colleagues, I introduced Joint Resolutions of Disapproval seeking to
PREPARED REMARKS: Sanders Leads HELP Committee Hearing with Novo Nordisk CEO on Outrageous Ozempic and Wegovy Prices
WASHINGTON, Sept. 24 – As millions of Americans struggle with diabetes and obesity, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today led the committee in a hearing to examine why Novo Nordisk charges the American people the highest prices in the world for its lifesaving drugs, Ozempic and Wegovy. Epidemiologists have
NEWS: Sanders Releases New Report, PBMs Welcome Lower List Prices for Ozempic and Wegovy
Three major Pharmaceutical Benefit Managers (PBMs) confirmed that lower list prices would make the blockbuster drugs more widely available WASHINGTON, Sept. 24 – Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released a new report uncovering how Novo Nordisk, as one health insurance plan described it, is using its “position of power”
NEWS: Sanders, Vermont State Dental Society, University of Detroit Mercy, and Welch Announce Historic Effort to Advance Dental Care and Education Across State
BURLINGTON, Vt., Sept. 20 — Sen. Bernie Sanders (I-Vt.), the Vermont State Dental Society (VSDS), University of Detroit Mercy (UDM), and Sen. Peter Welch (D-Vt.) today announced their historic effort to establish an innovative, new dental clinic and training program in Vermont. Through a VSDS-University of Detroit Mercy partnership, the initiative will bring UDM students to Vermont to complete their
MEDIA ADVISORY: Sanders to Lead HELP Committee Hearing on Outrageous Ozempic and Wegovy Prices with Novo Nordisk CEO
WASHINGTON, Sept. 20 – As millions of Americans struggle with diabetes and obesity, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), on Tuesday will lead the committee in a hearing to examine why Novo Nordisk charges the American people the highest prices in the world for its lifesaving drugs, Ozempic and Wegovy.
